Sarcopenia is prevalent in patients with Crohn's disease in clinical remission. - Wikidata - awgldk - TriplyDB

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

http://www.wikidata.org/entity/Q34591955

about

Body Mass Index Is Associated with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis The role of physical exercise in inflammatory bowel disease Review article: vitamin D and inflammatory bowel disease--established concepts and future directions Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease Clinical definition of sarcopenia Systematic review: body composition in adults with inflammatory bowel disease.Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease.Nutritional status and nutritional therapy in inflammatory bowel diseases.The bone and fat connection in inflammatory bowel diseases.Optimal vitamin D levels in Crohn's disease: a review.Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.Body composition analysis using abdominal scans from routine clinical care in patients with Crohn's Disease.Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease.Sarcopenia is associated with an increased risk of advanced colorectal neoplasia.The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm.Effects of a structured exercise programme in sedentary dogs with chronic diarrhoea.Visceral adiposity predicts post-operative Crohn's disease recurrence.Impact of biological therapy on body composition of patients with Chron's disease.Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease.Prevalence of Sarcopenia and Its Impact on Postoperative Outcome in Patients With Crohn's Disease Undergoing Bowel Resection.Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease.Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia

P2860

Q26776419-BE6A7820-2337-43C3-AA59-31CA0A2BA931 Q26865777-C56BC05E-1F9A-4246-BF71-EF8510051440 Q27015639-1A647886-8B8C-443E-8E2C-212D1AEF2972 Q33828933-9CA4EFCF-AE51-4CB3-A21A-F638CFD02C16 Q34023127-73BB4148-FAC7-4087-9ACE-B73E26A48479 Q34457203-F307B2EE-0177-4CCA-AA22-468273B4B21B Q34771160-713E4D33-6641-416C-81AA-465C71DDAED7 Q35065914-611ABA4A-0DAE-44BE-BBBE-1F79B4983BCE Q37507819-6FC4CFCA-A0A3-4C38-A8E5-E24EDF8B1517 Q38225220-84FA224E-ED54-4C24-9DD6-4A466E587A11 Q38286526-6C6DB933-CDCB-4E1D-B410-B3F1E58951A4 Q39243081-44144ED9-5B68-49F5-98B6-9875A1AE1ADE Q39900078-15EA23CE-E013-4CBA-BDAB-42E48BF43CDA Q40402171-0BAD9EC9-4F94-4CA6-8071-83E4A6380062 Q41263747-7CB97543-A93B-43B3-9315-B12356E98AE1 Q47599401-C202812C-71B5-4A46-B9C8-4A0FBFFC33D0 Q48021336-2E9FADB3-9C72-4AC1-AD8C-31C1973E8102 Q48166032-08708A33-0862-406D-B8CD-67217887AE9F Q48187074-804E5A14-9DCB-4A0E-AAB7-9A7EC12EBC9B Q50525563-B29B28FE-499A-4858-95AA-9825E7E74F72 Q51064245-C3A30AB6-5E5F-4A3C-8D30-9E80273FD3AB Q52990234-59048D2A-E2A7-40F9-A2F2-A13F267C8018 Q54958011-6E4E06F8-4F15-41BF-8804-5A9D1470184E Q58773411-E87C1886-03B1-4FB3-98EA-1B6452C444A1

P2860

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

http://www.wikidata.org/entity/Q34591955

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

@en

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

@nl

type

label

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

@en

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

@nl

prefLabel

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

@en

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

@nl

P1433

Q34591955-91303D7F-5607-45AE-AD9F-9DF5F96E44D6

P1476

Q34591955-C2C36406-4900-4DD8-A539-18B4F2038165

P2093

Q34591955-04B0A370-3878-4AE7-8B59-0450C03EBB1E

Q34591955-1785D3FB-F758-4242-83CF-70CBC622DC95

Q34591955-6E424E9E-EA6C-48C9-BA42-404500546B05

Q34591955-78DA0DCB-CEBC-43E9-AC33-104CC723B2D7

Q34591955-79424FC6-D425-4D05-B148-CB78E3EE4B48

Q34591955-BCA227F2-596A-4476-9436-60F5CB29F6C1

P2860

Q34591955-05F0C461-F35E-4B7B-9FC0-F84F64BC4580

Q34591955-0E537516-1356-4E75-B100-AD98B0CA9D29

Q34591955-1A7F5A0C-9AF1-4DB4-A172-759532A0392B

Q34591955-2C3C57F9-C1D8-4111-84CF-22F34AF4B195

Q34591955-3E9E640E-B425-456E-8CD4-07F66BFD66CF

Q34591955-620FFF15-C9DD-4C6C-A460-954C9139FA42

Q34591955-661FED85-DA69-47FE-8DF8-7114DD59920B

Q34591955-72C0C743-02E8-4E2C-B2B6-F3334FBA1361

Q34591955-7D47E6BF-4835-4E75-BCA6-4CDA0E6CF7F6

Q34591955-83C42AB9-3C68-4A33-A031-9F924C844AC0

P304

Q34591955-ABC52680-FAFB-4ECF-90C9-D23D67798CD6

P31

Q34591955-36ADE84C-979E-4796-8219-3440FF67A4ED

P356

Q34591955-EBB41AB4-890B-4D30-A806-36D3D95B1C15

P433

Q34591955-760779B6-F23E-4B45-8C15-512C2C583893

P478

Q34591955-FEAE5B29-C7E5-423C-BB4D-216B3AB35A8F

P50

Q34591955-94926AB0-4239-46C5-80DC-4263CFFEED06

P577

Q34591955-0EC69D62-74BF-44EC-88F5-696C504C2856

P5875

Q34591955-50B2B8C7-8A03-474F-A396-CCFC1CEE005D

P698

Q34591955-BC921BD9-5605-4F28-9D7D-123108A5AF61

P921

Q34591955-76FED3B7-8BCE-4BF1-9C81-010043231A8D

P356

P1433

Inflammatory Bowel Diseases

P1476

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission

@en

P2093

Gilbert Zeanandin

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Wiroth

http://www.w3.org/2001/XMLSchema#string

Jerôme Filippi

http://www.w3.org/2001/XMLSchema#string

Kamel Arab

http://www.w3.org/2001/XMLSchema#string

Rima Al-Jaouni

http://www.w3.org/2001/XMLSchema#string

Xavier Hébuterne

http://www.w3.org/2001/XMLSchema#string

P2860

AGA technical review on osteoporosis in gastrointestinal diseases.

Sarcopenia--consequences, mechanisms, and potential therapies.

Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia.

The relation between immunology, nutrition and disease in elderly people.

Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women.

Tumor necrosis factor and cachexia: a current perspective.

Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls.

Effect of steroids on energy expenditure and substrate oxidation in women with Crohn's disease.

Nutritional deficiencies in patients with Crohn's disease in remission.

Relationship between body composition and bone mineral density in healthy young and premenopausal Chinese women.

P304

1562-1568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.20504

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Stéphane M. Schneider

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5372104

http://www.w3.org/2001/XMLSchema#string

P698

18478564

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease